207 related articles for article (PubMed ID: 25650553)
1. No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.
Groeneveld DJ; van Bekkum T; Cheung KL; Dirven RJ; Castaman G; Reitsma PH; van Vlijmen B; Eikenboom J
J Thromb Haemost; 2015 Apr; 13(4):592-600. PubMed ID: 25650553
[TBL] [Abstract][Full Text] [Related]
2. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
3. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.
O'Donnell J; Boulton FE; Manning RA; Laffan MA
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):335-41. PubMed ID: 11834538
[TBL] [Abstract][Full Text] [Related]
4. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
[TBL] [Abstract][Full Text] [Related]
5. The genetic basis of von Willebrand disease.
Goodeve AC
Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
Lethagen S; Kyrle PA; Castaman G; Haertel S; Mannucci PM;
J Thromb Haemost; 2007 Jul; 5(7):1420-30. PubMed ID: 17439628
[TBL] [Abstract][Full Text] [Related]
8. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.
O'Donnell J; Laffan MA
Transfus Med; 2001 Aug; 11(4):343-51. PubMed ID: 11532189
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
[TBL] [Abstract][Full Text] [Related]
10. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
[TBL] [Abstract][Full Text] [Related]
11. Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor.
Orstavik KH; Kornstad L; Reisner H; Berg K
Blood; 1989 Mar; 73(4):990-3. PubMed ID: 2493271
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of Haemate® P in von Willebrand disease: a 25-year retrospective observational study.
Miesbach W; Krekeler S; Wolf Z; Seifried E
Thromb Res; 2015 Mar; 135(3):479-84. PubMed ID: 25595881
[TBL] [Abstract][Full Text] [Related]
13. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
[TBL] [Abstract][Full Text] [Related]
14. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
[TBL] [Abstract][Full Text] [Related]
16. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
17. Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.
Bucciarelli P; Siboni SM; Stufano F; Biguzzi E; Canciani MT; Baronciani L; Pagliari MT; La Marca S; Mistretta C; Rosendaal FR; Peyvandi F
J Thromb Haemost; 2015 Feb; 13(2):228-36. PubMed ID: 25425019
[TBL] [Abstract][Full Text] [Related]
18. Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.
Bowman ML; Pluthero FG; Tuttle A; Casey L; Li L; Christensen H; Robinson KS; Lillicrap D; Kahr WHA; James P
J Thromb Haemost; 2017 Jul; 15(7):1403-1411. PubMed ID: 28453889
[TBL] [Abstract][Full Text] [Related]
19. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
[TBL] [Abstract][Full Text] [Related]
20. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
